skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 153247 Add to Shopping cart Find in a Library
Title: Oversight of the Drug Enforcement Administration
Corporate Author: US Congress
Senate Subcommittee on Security and Terrorism
United States of America
Date Published: 1981
Page Count: 51
Sponsoring Agency: National Institute of Justice/
Rockville, MD 20849
NCJRS Photocopy Services
Rockville, MD 20849-6000
Superintendent of Documents, GPO
Washington, DC 20402
US Congress
Washington, DC 20510
Sale Source: Superintendent of Documents, GPO
Washington, DC 20402
United States of America

National Institute of Justice/
NCJRS paper reproduction
Box 6000, Dept F
Rockville, MD 20849
United States of America

NCJRS Photocopy Services
Box 6000
Rockville, MD 20849-6000
United States of America
Document: PDF
Type: Legislative Hearing/Committee Report
Language: English
Country: United States of America
Annotation: This report contains the text of a hearing before the U.S. Senate Subcommittee on Security and Terrorism regarding oversight of the Drug Enforcement Administration.
Abstract: The chief witness was the Administrator of the Drug Enforcement Administration, who addressed issues related to the connection between drugs and national security, the factors that cause young people to use illegal drugs, and the efforts being expended by the Federal Government to enforce drug laws. According to this testimony, 90 percent majority of so-called dangerous drugs, which account for 23 percent of the domestic illicit drug market, are manufactured in the U.S. Of these, at least two-thirds, including barbiturates, amphetamines, and methamphetamines, are manufactured legally and represent overprescription or specific, purposeful criminal diversion. The Administrator discussed the connections between the Sicilian mafia and exporters of Southwest Asian heroin, the Federal drug strategy, the implications of the Gambino case for drug law enforcement, and characteristics of clandestine laboratory operations.
Main Term(s): Drug law enforcement
Index Term(s): Clandestine laboratory enforcement programs; Drug Enforcement Administration (DEA); Drug manufacturing; Organized crime
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.